BR100 Decreased By (-0.36%)
BR30 Decreased By (-0.72%)
KSE100 Decreased By (-0.33%)
KSE30 Decreased By (-0.31%)
AGHA 6.59 Decreased By ▼ -0.08 (-1.2%)
BECO 4.40 Increased By ▲ 0.05 (1.15%)
BML 55.20 Decreased By ▼ -0.97 (-1.73%)
BOP 29.95 Decreased By ▼ -0.17 (-0.56%)
CNERGY 12.69 Decreased By ▼ -0.29 (-2.23%)
CSIL 5.22 Decreased By ▼ -0.09 (-1.69%)
FCCL 51.10 Decreased By ▼ -0.55 (-1.06%)
FFL 14.44 Decreased By ▼ -0.05 (-0.35%)
FNEL 1.19 Decreased By ▼ -0.02 (-1.65%)
KEL 5.97 Decreased By ▼ -0.09 (-1.49%)
KOSM 5.59 Decreased By ▼ -0.25 (-4.28%)
LOTCHEM 26.25 Increased By ▲ 0.08 (0.31%)
MLCF 90.56 Decreased By ▼ -0.67 (-0.73%)
NBP 162.20 Decreased By ▼ -1.99 (-1.21%)
NCPL 52.69 Decreased By ▼ -0.49 (-0.92%)
NPL 57.90 Decreased By ▼ -1.22 (-2.06%)
OGDC 314.00 Increased By ▲ 0.61 (0.19%)
PACE 9.68 Decreased By ▼ -0.09 (-0.92%)
PAEL 34.95 Decreased By ▼ -0.29 (-0.82%)
PIBTL 14.23 Decreased By ▼ -0.48 (-3.26%)
PPL 219.70 Decreased By ▼ -1.66 (-0.75%)
PRL 89.78 Decreased By ▼ -1.44 (-1.58%)
PTC 59.01 Decreased By ▼ -0.18 (-0.3%)
SSGC 23.25 Decreased By ▼ -0.05 (-0.21%)
TBL 8.68 Decreased By ▼ -0.07 (-0.8%)
TELE 7.39 Decreased By ▼ -0.22 (-2.89%)
TPL 21.15 Decreased By ▼ -0.88 (-3.99%)
TPLP 12.19 Decreased By ▼ -0.37 (-2.95%)
TREET 21.39 Decreased By ▼ -0.34 (-1.56%)
TRG 54.43 Decreased By ▼ -1.36 (-2.44%)
World

EU says Pfizer/BioNTech to deliver 75 million extra vaccine doses in second quarter

  • "BioNTech/Pfizer will deliver 75 million of additional doses in the second quarter of the year - and up to 600 millions in total in 2021," von der Leyen wrote on Twitter.
Published Updated
By

BRUSSELS Pfizer and German partner BioNTech will deliver 75 million extra doses of their COVID-19 vaccine in the second quarter of the year, European Commission President Ursula von der Leyen said on Monday.

"BioNTech/Pfizer will deliver 75 million of additional doses in the second quarter of the year - and up to 600 millions in total in 2021," von der Leyen wrote on Twitter.

The EU, whose member states are far behind Israel, Britain and the United States in rolling out vaccines, is scrambling to get supplies just as the West's biggest drugmakers slow deliveries to the bloc due to production problems.

Comments

Comments are closed for this article.